CG
CBST

Clinton Group’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Clinton Group’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-6,559
Closed -$435K – 634
2014
Q3 		$435K Buy
+6,559
New +$431K 0.18% 202

Other funds holding CBST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Clinton Group's CBST Position: Q4 2014 in Review

Clinton Group sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q4 2014, closing a stake of 6,559 shares — an estimated $435K sold.

Clinton Group first reported a position in CBST in Q3 2014 and held it in 1 quarter. The position peaked at $435K in Q3 2014. 307 funds tracked by Wall St. Rank hold CBST as of Q4 2014.

  • Clinton Group reported no remaining CUBIST PHARMACEUTICALS INC position as of Q4 2014 after selling out during the quarter.
  • Clinton Group sold 6,559 CUBIST PHARMACEUTICALS INC shares in Q4 2014, an estimated $435K.
  • Clinton Group first reported a position in CUBIST PHARMACEUTICALS INC in Q3 2014 and held it in 1 quarter.
  • Clinton Group's CUBIST PHARMACEUTICALS INC position peaked at $435K in Q3 2014.
  • 307 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q4 2014.

Based on Clinton Group's 13F filing for Q4 2014, filed 13 Feb 2015.